CTOs on the Move

Intrinsic Therapuetics

www.in-thera.com

 
Intrinsic Therapuetics is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Rachael Nelsen
VP QA/RA Profile

Funding

Intrinsic Therapuetics raised $28M on 05/10/2017

Similar Companies

OXiGENE

OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.

Fermatex

Fermatex Vascular Technologies, LLC is an industry-leading designer and manufacturer of high pressure braided tubing, complex medical extrusions and advanced catheters used throughout the medical device industry.

GT Medical Technologies

Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 95 hospitals, with more centers being added each month.

Pleomorphic Product Sales

Pleomorphic Product Sales is a Glendale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gateway Medical

Gateway Medical is a Davidson, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.